Opportunity

SAM #36C24726Q0651

Sole Source Service and Support for DiaSorin Liaison XL at Augusta VA Medical Center

Buyer

VANCO 7

Posted

June 30, 2026

Respond By

July 13, 2026

Identifier

36C24726Q0651

NAICS

334516, 423490, 811219

This notice announces the Department of Veterans Affairs' intent to award a sole source contract for laboratory equipment service and supplies. - Agency: Department of Veterans Affairs, Network Contracting Office 7 (NCO 07), Augusta VA Medical Center - Sole source vendor: DiaSorin Inc. - Equipment: DiaSorin Liaison XL laboratory analyzer - Products: LIAISON QuantiFERON TB Gold Plus Kits and Controls - Services: Maintenance and support performed exclusively by DiaSorin-trained personnel - Rationale: DiaSorin is the exclusive manufacturer and only authorized provider; third-party maintenance would void warranties - Competition: Not open unless a qualified vendor can demonstrate clear advantages - Period of performance: Not specified in the notice - Commercial opportunity: Sole source service and supply contract for specialized laboratory equipment

Technical Details - Only DiaSorin Inc. can supply the required kits, controls, and maintenance - All equipment, supplies, and services must meet DiaSorin specifications - No other vendors are authorized or certified for these services - Maintenance must be performed by manufacturer-trained personnel - Warranty compliance requires exclusive DiaSorin service

Description

Federal Acquisition Regulation (FAR) Subpart 5.101 and 12.202 (Publicizing) requiring dissemination of information for proposed contract actions. This is a notice of intent to award a sole source contract and it s not a request for competitive quotes/proposals. The Department of Veterans Affairs, Network Contracting Office (NCO) 07, Augusta VA Medical Center, 950 15th Street, Augusta, GA 30901 and is issuing this Notice of Intent (NOI) to inform industry contractors of the Government s intent to execute a Sole Source requirement under FAR Part 6.302-1 for restricting competition on this procurement. Only responsible Available Source and no other Supplies or Services will satisfy Agency requirement. The contractor is DiaSorin Inc., 1951 Northwestern Avenue, Stillwater, MN 55082-0285. The place of performance is at the Augusta VA Medical Center, 950 15th Street, Augusta, GA 30901. This contract is to provide service and support for the Pathology Laboratory Department at the Department of Veterans Affairs Medical Center in Augusta, GA. Services shall be performed by the manufacturer and trained service personnel. All equipment, supplies, and services shall be maintained in proper operating conditions as specified by DiaSorin Inc DiaSorin Inc. is the exclusive manufacturer and provider of LIAISON® QuantiFERON TB Gold Plus Kits and LIAISON® QuantiFERON TB Gold Plus Controls products and services, and the sole company capable of performing services and supplying products for DiaSorin Inc. DiaSorin Inc does not currently have any authorization or certification process in place for companies performing service, maintenance and providing supplies for DiaSorin Inc equipment. Any service or maintenance performed by a third-party vendor, other than our Field Service Technician Affiliates, would render null and void any existing warranty and be unsupported by DiaSorin Inc. This notice of intent is neither a formal solicitation nor a request for competitive proposals. No solicitation document is available, and telephone requests will not be honored. No award will be made on the basis of unsolicited quotations or offers received in response to this notice. Any response to this notice must show clear, compelling and convincing evidence that competition will be advantageous to the Government. The intent of this synopsis is for informational purposes only. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. A determination by the Government not to compete this action based on this notice is solely within the discretion of the Government. All inquiries and concerns must be addressed in writing via e-mail to Earnest Ellison, earnest.ellison@va.gov with the following information referenced in the subject line, 36C24726Q0651, DiaSorin Liaison XL. All interested parties who are responsible, certified, and capable may identify their interest and may submit a capabilities statement no later than 3:00 PM Eastern Standard Time (EST) on July 17, 2026, to Earnest Ellison, earnest.ellison@va.gov. The interested parties bear full responsibility to ensure complete transmission and timely receipt. Additional Links:https://www.va.gov

View original listing